Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Cosmos Health Inc. (COSM)

Cosmos Health reports record preliminary nine-month revenue of $54.3 million, up 19%

Positive Impact 3 of 5 earnings Written later

Cosmos Health reported preliminary, unaudited revenue of about $54.3 million for the nine months ended September 30, 2026, up 19% from $45.6 million a year earlier, and about $17.4 million for the third quarter. The company reaffirmed its expectation that full-year 2026 revenue will surpass $90 million, which matters to shareholders because it signals continued growth, though the figures are preliminary and the complete third-quarter results are not yet reported.

Key points

  • Nine-month 2026 revenue of about $54.3 million, up $8.7 million, or 19%, from $45.6 million in the same period of 2025
  • Third-quarter 2026 revenue of about $17.4 million, compared with a record $17.1 million in the third quarter of 2025
  • Full-year 2026 revenue outlook of over $90 million reaffirmed; the company expects the fourth quarter to be its strongest ever
  • Figures are preliminary and unaudited; complete third-quarter results will be reported in the Form 10-Q

The filing

CompanyCosmos Health Inc. (COSM)
Form8-K, current report
Filed with the SECOct 9, 2026, 5:00 PM ET
Accession number0001477932-26-006158

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 09, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.